Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	98.29B
Revenue (ttm)	21.32B
Net Income (ttm)	4.15B
Shares Out	124.10M
EPS (ttm)	30.85
PE Ratio	20.87
Forward PE	20.46
Dividend	11.67 (1.53%)
Ex-Dividend Date	Jun 20, 2025

Volume	1,762,296
Average Volume	1,206,999
Open	770.00
Previous Close	765.00
Day's Range	770.00 - 795.00
52-Week Range	468.72 - 795.00
Beta	0.77
RSI	80.34
Earnings Date	Aug 11, 2025

About TPE:6472

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.